SCHEMBL18173525

SCHEMBL18173525

CC(C)(C)C(=O)Oc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.71
MEN1 O00255 3/20 0.71
KMT2A Q03164 3/20 0.71
LMNA P02545 3/20 0.71
ALDH1A1 P00352 3/20 0.71
HTT P42858 2/20 0.71
USP2 O75604 1/20 0.71
FTO Q9C0B1 9/20 0.70
TDP1 Q9NUW8 2/20 0.70
HPGD P15428 2/20 0.70
CYP2C19 P33261 1/20 0.70
RECQL P46063 1/20 0.70
BLM P54132 1/20 0.70
SMAD3 P84022 1/20 0.70
PRMT1 Q99873 1/20 0.70
ACE2 Q9BYF1 1/20 0.70
CYP3A4 P08684 2/20 0.59
GPR55 Q9Y2T6 2/20 0.54
ALOX12 P18054 2/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5058843 0.96 MAPT (0.77) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL18127013 0.93 MAPT (0.69) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL16745699 0.90 MAPT (0.66) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL2285435 0.89 MAPT (0.89) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL16342038 0.89 MAPT (0.64) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL1644447 0.88 MAPT (0.87) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL5174468 0.88 FTO (0.75) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL700722 0.87 FTO (0.73) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL22434156 0.87 FTO (0.73) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL23083080 0.87 FTO (0.73) MAPTMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180092845-A1 ENZYME-RESPONSIVE NANOPARTICLES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-04-05 US disclosed
WO-2016172386-A1 ENZYME-RESPONSIVE NANOPARTICLES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-10-27 WO disclosed
CN-101451018-A Yellow fluorochrome and synthetic method and use thereof UNIV NORTHWESTERN (CN) 2009-06-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180092845-A1 ENZYME-RESPONSIVE NANOPARTICLES TNNI3, TNNT2, TNNC1 MAPT 3432/4885MEN1 3170/4885KMT2A 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.